Vivos Inc. Issues Corrective Press Release Regarding Reverse Stock Split
June 27, 2019 15:07 ET
|
Vivos Inc.
Richland, WA, June 27, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (the “Company”) (OTC PINK: RDGL), a company engaged in the development and commercialization of minimally invasive brachytherapy...
Vivos Inc. Announces 1-for-8 Reverse Stock Split
June 26, 2019 07:00 ET
|
Vivos Inc.
Richland, WA, June 26, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (the “Company”) (OTC PINK: RDGL), a company engaged in the development and commercialization of minimally invasive brachytherapy...
Vivos Inc. Reports Progress
April 30, 2019 07:00 ET
|
Vivos Inc.
Richland WA, April 30, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCPINK: RDGL), provides an update on the progress towards commercialization of Y-90 IsoPet® for animal therapy. Animal...
Vivos Inc Retains Well-Known Analyst, George Sharp, as Advisor - Updated
September 25, 2018 11:12 ET
|
Vivos Inc.
Richland, WA, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Vivos Inc. (OTC: RDGL), a pharmaceutical company in the process of researching and developing minimally invasive treatments to combat cancer in...
Vivos Inc Obtains Trademark Protection for IsoPet®
July 30, 2018 06:00 ET
|
Vivos Inc.
Richland, WA, July 30, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) obtains IsoPet trademark protection. The U.S. Patent and Trademark Office (“USPTO”) issued the Certificate of Registration...